Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study.
Artificial inteligence
Epilepsy
Machine learning
Temporal lobe epilepsy
Journal
NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
01
2021
revised:
15
07
2021
accepted:
17
07
2021
pubmed:
3
8
2021
medline:
14
9
2021
entrez:
2
8
2021
Statut:
ppublish
Résumé
Artificial intelligence has recently gained popularity across different medical fields to aid in the detection of diseases based on pathology samples or medical imaging findings. Brain magnetic resonance imaging (MRI) is a key assessment tool for patients with temporal lobe epilepsy (TLE). The role of machine learning and artificial intelligence to increase detection of brain abnormalities in TLE remains inconclusive. We used support vector machine (SV) and deep learning (DL) models based on region of interest (ROI-based) structural (n = 336) and diffusion (n = 863) brain MRI data from patients with TLE with ("lesional") and without ("non-lesional") radiographic features suggestive of underlying hippocampal sclerosis from the multinational (multi-center) ENIGMA-Epilepsy consortium. Our data showed that models to identify TLE performed better or similar (68-75%) compared to models to lateralize the side of TLE (56-73%, except structural-based) based on diffusion data with the opposite pattern seen for structural data (67-75% to diagnose vs. 83% to lateralize). In other aspects, structural and diffusion-based models showed similar classification accuracies. Our classification models for patients with hippocampal sclerosis were more accurate (68-76%) than models that stratified non-lesional patients (53-62%). Overall, SV and DL models performed similarly with several instances in which SV mildly outperformed DL. We discuss the relative performance of these models with ROI-level data and the implications for future applications of machine learning and artificial intelligence in epilepsy care.
Identifiants
pubmed: 34339947
pii: S2213-1582(21)00209-6
doi: 10.1016/j.nicl.2021.102765
pmc: PMC8346685
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102765Subventions
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : R01 EB015611
Pays : United States
Organisme : Medical Research Council
ID : MR/L016311/ 1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS122827
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : Medical Research Council
ID : MR/L016311/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS065838
Pays : United States
Organisme : NIH HHS
ID : S10 OD023696
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110347
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS107739
Pays : United States
Organisme : Medical Research Council
ID : MR/S00355X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023152/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013998/1
Pays : United Kingdom
Investigateurs
Andre Altmann
(A)
Chantal Depondt
(C)
Marian Galovic
(M)
Sophia I Thomopoulos
(SI)
Roland Wiest
(R)
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.